Kura Oncology (KURA) Return on Sales (QoQ) (2025 - 2026)

Kura Oncology (KURA) Return on Sales (QoQ) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,681.27 Bn	66,680.98 Bn	-
2	Nanobiotix	1,911.83 Bn	1,911.77 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	472.75 Bn	467.96 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.14 Bn	114.89 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.09 Bn	61.34 Bn	3.31 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-
8	Argenx Se	55.94 Bn	50.76 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.52 Bn	34.51 Bn	959.66 Mn
10	Kura Oncology	921.10 Mn	921.10 Mn	18.00 Mn

Download Data